DefinitionThis section has been translated automatically.
Semaglutide s.c. (Ozempic®) (1 x weekly)
for the treatment of inadequately controlled type 2 DM as an adjunctive therapy to dietary changes and more exercise, possibly in addition to metformin or other antidiabetic drugs (adults)
Semaglutide s.c. (Wegovy®) (1 x weekly)
for weight reduction as an accompanying therapy to dietary changes and more exercise. (adults, children and adolescents aged 12 and over).
Semaglutide oral (Rybelsus®) (Approved, but not yet on the market in Germany, as of 2/2025)
LiteratureThis section has been translated automatically.
Specialist information Red List Semaglutide (Ozempic®) Novo Nordisk
Specialist information Red List Semaglutide (Wegovy®) Novo Nordisk
